Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial

Hanieh Azizi,Nima Rouhani,Fatemeh Shaki,Elahe Karimpour-Razkenari,Monireh Ghazaeian,Ebrahim Salehifar,Majid Saeedi,Sahar Fallah

International Immunopharmacology（2021）

引用 5|浏览7

暂无评分

摘要

•Pentoxifylline exerted a beneficial effect on inflammatory biomarkers.•Pentoxifylline showed no benefit on improving the clinical outcomes of COVID-19.•Pentoxifylline caused no specific adverse effect.

查看译文

关键词

Pentoxifylline,COVID-19,Inflammation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要